Capnography for catheter location confirmation in minimally invasive surfactant administration.


Journal

Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884

Informations de publication

Date de publication:
03 2023
Historique:
received: 07 08 2022
accepted: 23 01 2023
revised: 22 12 2022
pubmed: 1 2 2023
medline: 10 3 2023
entrez: 31 1 2023
Statut: ppublish

Résumé

Minimally Invasive Surfactant Treatment (MIST) is a common method for administering surfactant as a treatment for respiratory distress syndrome. However, tracheal catheter placement can be difficult to confirm. We assessed the presence of carbon dioxide (CO Retrospective arm: 20 infants, MIST catheter placement was assessed with a CO Retrospective arm: All infants had positive capnography. One infant that had no clinical response to MIST was diagnosed with total anomalous pulmonary venous return. All 10 infants of the prospective arm had a Negative capnography (P < 0.001, Fisher's exact test). Readily available CO

Identifiants

pubmed: 36720984
doi: 10.1038/s41372-023-01624-5
pii: 10.1038/s41372-023-01624-5
doi:

Substances chimiques

Surface-Active Agents 0
Carbon Dioxide 142M471B3J
Pulmonary Surfactants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300-304

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European consensus guidelines on the management of respiratory distress syndrome—2016 update. Neonatol [Internet]. 2017;111:107–25.
doi: 10.1159/000448985
Abdel-Latif ME, Davis PG, Wheeler KI, De Paoli AG, Dargaville PA. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2021;5:CD011672. https://doi.org/10.1002/14651858.CD011672.pub2 .
Klebermass-Schrehof K, Wald M, Schwindt J, Grill A, Prusa A-R, Haiden N, et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology. 2013;103:252–8.
doi: 10.1159/000346521 pubmed: 23446061
Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child—Fetal Neonatal Ed. 2010;96:F243–8.
doi: 10.1136/adc.2010.192518 pubmed: 20971722
Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378:1627–34.
doi: 10.1016/S0140-6736(11)60986-0 pubmed: 21963186
Kribs A, Härtel C, Kattner E, Vochem M, Küster H, Möller J, et al. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klinische Pädiatrie. 2010;222:13–7.
doi: 10.1055/s-0029-1241867 pubmed: 20084586
Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child—Fetal Neonatal Ed. 2016;102:F17–23.
doi: 10.1136/archdischild-2015-310299 pubmed: 27852668
Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kutman HGK, et al. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: The OPTIMIST-A randomized clinical trial. JAMA. 2021;326:2478–87. https://doi.org/10.1001/jama.2021.21892
doi: 10.1001/jama.2021.21892 pubmed: 34902013
Roberts CT, Halibullah I, Bhatia R, Green EA, Kamlin COF, Davis PG, et al. Outcomes after introduction of minimally invasive surfactant therapy in two Australian tertiary neonatal units. J Pediatrics. 2021;229:141–6.
doi: 10.1016/j.jpeds.2020.10.025
Starship.org.nz. gatsby-starship;2021. Available from: https://starship.org.nz/guidelines/practice-recommendation-for-lisa-mist/ .

Auteurs

Itamar Nitzan (I)

Shaare Zedek Medical Center, Jerusalem, Israel. itamarnitzan@gmail.com.
Department of Pediatrics, Hebrew University of Jerusalem Medical School, Jerusalem, Israel. itamarnitzan@gmail.com.

Rawan Abu Omar (R)

Shaare Zedek Medical Center, Jerusalem, Israel.
Department of Pediatrics, Hebrew University of Jerusalem Medical School, Jerusalem, Israel.

Francis B Mimouni (FB)

Shaare Zedek Medical Center, Jerusalem, Israel.
Sackler Faculty of Medicine Tel Aviv University, Tel Aviv, Israel.

Dvora Burshtein-Sorotzkin (D)

Shaare Zedek Medical Center, Jerusalem, Israel.

Naomi Algavish-Landau (N)

Shaare Zedek Medical Center, Jerusalem, Israel.

Sivan Attia-Reches (S)

Shaare Zedek Medical Center, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH